EP508: Integration of personalized medicine into primary care clinics: A path to make large scale population genomics studies successful

Abstract

Many health systems are now offering population-scale genomic screening programs. A common approach is to provide access to CDCT1 conditions - hereditary breast and ovarian cancer syndrome, Lynch syndrome and familial hypercholesterolemia - a panel that has been shown to identify a significant proportion of at-risk patients who have not been previously identified through existing guidelines and clinical care. The potential benefit to ascertaining all patients at risk for actionable conditions is to identify them as early as possible and ensure that they engage in appropriate clinical care paths.